BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25566565)

  • 1. Inflammatory acne: new developments in pathogenesis and treatment.
    Rosen J; Friedman AJ
    Cutis; 2014 Dec; 94(6):266-7. PubMed ID: 25566565
    [No Abstract]   [Full Text] [Related]  

  • 2. Different strains of Propionibacterium acnes modulate differently the cutaneous innate immunity.
    Jasson F; Nagy I; Knol AC; Zuliani T; Khammari A; Dréno B
    Exp Dermatol; 2013 Sep; 22(9):587-92. PubMed ID: 23947673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Propionibacterium acnes in acne pathogenesis: facts and controversies.
    Dessinioti C; Katsambas AD
    Clin Dermatol; 2010; 28(1):2-7. PubMed ID: 20082942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is acne caused by colonization with the "wrong" strain of Propionibacterium acnes? A review of the role of Propionibacterium acnes in acne].
    Lomholt HB; Kilian M
    Ugeskr Laeger; 2008 Apr; 170(15):1234-7. PubMed ID: 18433578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic effect of tanshinone IIA on Propionibacterium acnes-induced inflammation in vitro.
    Li Y; Zhou Y
    Dermatol Ther; 2018 Nov; 31(6):e12716. PubMed ID: 30246913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-evaluating treatment targets in acne vulgaris: adapting to a new understanding of pathophysiology.
    Kircik LH
    J Drugs Dermatol; 2014 Jun; 13(6):s57-60. PubMed ID: 24918572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of acne vulgaris: recent advances.
    Bhambri S; Del Rosso JQ; Bhambri A
    J Drugs Dermatol; 2009 Jul; 8(7):615-8. PubMed ID: 19588637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses.
    Kim J
    Dermatology; 2005; 211(3):193-8. PubMed ID: 16205063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different pro-inflammatory and immunogenic potentials of Propionibacterium acnes and Staphylococcus epidermidis: implications for chronic inflammatory acne.
    Białecka A; Mak M; Biedroń R; Bobek M; Kasprowicz A; Marcinkiewicz J
    Arch Immunol Ther Exp (Warsz); 2005; 53(1):79-85. PubMed ID: 15761379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propionibacterium acnes: an update on its role in the pathogenesis of acne.
    Beylot C; Auffret N; Poli F; Claudel JP; Leccia MT; Del Giudice P; Dreno B
    J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):271-8. PubMed ID: 23905540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does inflammatory acne result from imbalance in the keratinocyte innate immune response?
    Grange PA; Weill B; Dupin N; Batteux F
    Microbes Infect; 2010 Dec; 12(14-15):1085-90. PubMed ID: 20691803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of acne vulgaris: what's new, what's interesting and what may be clinically relevant.
    Bellew S; Thiboutot D; Del Rosso JQ
    J Drugs Dermatol; 2011 Jun; 10(6):582-5. PubMed ID: 21637898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolving role of Propionibacterium acnes in acne.
    Leyden JJ
    Semin Cutan Med Surg; 2001 Sep; 20(3):139-43. PubMed ID: 11594668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy for acne vulgaris: current status and future directions.
    Simonart T
    Am J Clin Dermatol; 2013 Dec; 14(6):429-35. PubMed ID: 24019180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoding acne: genetic markers, molecules, and Propionibacterium acnes.
    J Drugs Dermatol; 2013 Jun; 12(6):s64-5. PubMed ID: 23839201
    [No Abstract]   [Full Text] [Related]  

  • 16. Evolving concepts in the pathogenesis of acne vulgaris.
    Kircik LH
    J Drugs Dermatol; 2014 Jun; 13(6):s56. PubMed ID: 24918571
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of toll-like receptors by Propionibacterium acnes.
    Jugeau S; Tenaud I; Knol AC; Jarrousse V; Quereux G; Khammari A; Dreno B
    Br J Dermatol; 2005 Dec; 153(6):1105-13. PubMed ID: 16307644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do we really need topical antibiotics in our new treatment paradigm of acne vulgaris? A novel question to consider based on an updated model of pathogenesis.
    Kircik LH
    J Drugs Dermatol; 2013 Aug; 12(8 Suppl):s107. PubMed ID: 23986174
    [No Abstract]   [Full Text] [Related]  

  • 19. Acne: a new model of immune-mediated chronic inflammatory skin disease.
    Antiga E; Verdelli A; Bonciani D; Bonciolini V; Caproni M; Fabbri P
    G Ital Dermatol Venereol; 2015 Apr; 150(2):247-54. PubMed ID: 25876146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acne: evolving concepts of pathogenesis need to guide therapeutic developments.
    Weiss JS
    J Drugs Dermatol; 2013 Jun; 12(6):s66. PubMed ID: 23839202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.